Webinar with Tom Culver was very impressive. The appeal loss to...

Webinar with Tom Culver was very impressive. The appeal loss to Fred IT is now past history and it is onward and upwards. Potential growth in adding more suppliers to the PharmXchange Marketplace platform is going to be the catalyst. Fees received on transactions between potentially up to 400 suppliers across a combined market of nearly 6000 retail pharmacy, hospitals, goverment agencies like NDIS, National Diabetic Scheme represent a cash cow of significant proportions. This Marketplace platform has only been operational for around 12 months. With PharmX already making inroads in NZ, expansion into SE Asia beckons as well acording to Tom. I don't see any reason that this innovative B2B technology can't find its way into the US pharmacy space. Look what MedAdvisor has been able to achieve a company that Nick England was associated with during its formative years. MedAdvisor's growing US business links patients/pharmacies/pharmaceutical manufacturers I think PharmXchange would be natural fit as an add-on to MedAdvisor's operations (by licence or some other mutually beneficial arrangement - start talking).